Wedbush Keeps Outperform on Dianthus Therapeutics, Inc. (DNTH), Highlights Potential of Claseprubart in CIDP.
Share this article
Corporate
Score 35
Bullish
Wedbush Keeps Outperform on Dianthus Therapeutics, Inc. (DNTH), Highlights Potential of Claseprubart in CIDP
Mar 18, 2026 21:14 UTC
DNTH, CL=F, ^VIX
Short term
Related Articles
Score 65
Gold rebounds, but silver extends losses as oscillating oil prices spark market volatility
Mar 20, 10:38
Score 45
Combat Oil Shock With Demand Hacks Like Work-From-Home, IEA Says
Mar 20, 10:30
Score 5
I’m 30 and want to save $420,000 in 10 years. But I work for the Fed and can’t invest in bank-specific ETFs. What are my
Mar 20, 10:30
Score 85
Bearish
ECB's Makhlouf Can 'Understand' Expectations of Two Hikes
Mar 20, 10:17
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.